Transcriptomic and Biochemical Analysis of the Antimicrobial Mechanism of Lipopeptide Iturin W against Staphylococcus aureus
International Journal of Molecular Sciences · 15.09.2024 · 25 (18) · 9949
DOI: 10.3390/ijms25189949 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 15.09.2024. Verfasst von Yingyu Ji und 2 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Sciences, Qingdao University, Qingdao 266071, China. Hauptthemen laut MEDLINE: Staphylococcus aureus, Reactive Oxygen Species, Transcriptome. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shandong Provincial Natural Science Foundation, National Natural Science Foundation of China, Science and Technology Innovation Project of Laoshan Laboratory.
Abstract (Originalsprache)
Staphylococcus aureus is one of the most serious pathogens threatening food safety and public health. We have previously showed that iturin W exhibited obvious antifungal activity on plant pathogens. In the present study, we found iturin W, especially C14 iturin W, showed strong antimicrobial activity against S. aureus, and the antimicrobial mechanism of C14 iturin W was further investigated by transcriptomic analysis and a related biochemical experiment. The results showed that C14 iturin W can reduce the expression levels of genes associated with the reactive oxygen species (ROS) scavenging enzyme and genes involved in arginine biosynthesis, thus leading to the increase in ROS levels of S. aureus. Furthermore, C14 iturin W can also interfere with proton dynamics, which is crucial for cells to regulate various biological possesses. Therefore, ROS accumulation and change in proton motive force are import ways for C14 iturin W to exert the antimicrobial activity. In addition, C14 iturin W can also reduce the expression levels of genes related to virulence factors and decrease the production of enterotoxins and hemolysins in S. aureus, indicating that C14 iturin W has a good potential in food and pharmaceutical fields to reduce the harm caused by S. aureus in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Life Sciences, Qingdao University, Qingdao 266071, China.
- CAS Key Laboratory of Experimental Marine Biology, Institute of Oceanology, Chinese Academy of Sciences, Qingdao 266071, China.
- Laboratory for Marine Biology and Biotechnology, Qingdao National Laboratory for Marine Science and Technology, Qingdao 266071, China.
- Center of Ocean Mega-Science, Chinese Academy of Sciences, Qingdao 266071, China.
ORCID-Profile: Chaomin Sun
Förderung
- Shandong Provincial Natural Science Foundation
- National Natural Science Foundation of China
- Science and Technology Innovation Project of Laoshan Laboratory
- NSFC Innovative Group
- Key Collaborative Research Program of the Alliance of International Science Organizations
- Major Research Plan of the National Natural Science Foundation
- Strategic Priority Research Program of the Chinese Academy of Sciences
- Taishan Scholars Program
Zitieren
APA
Ji, Y., Sun, C., & Wu, S. (2024). Transcriptomic and Biochemical Analysis of the Antimicrobial Mechanism of Lipopeptide Iturin W against Staphylococcus aureus. International Journal of Molecular Sciences, 25(18), 9949. https://doi.org/10.3390/ijms25189949
Vancouver
Ji Y, Sun C, Wu S. Transcriptomic and Biochemical Analysis of the Antimicrobial Mechanism of Lipopeptide Iturin W against Staphylococcus aureus. International Journal of Molecular Sciences. 2024;25(18):9949. doi:10.3390/ijms25189949
BibTeX
@article{Ji2024,
author = {Ji, Yingyu and Sun, Chaomin and Wu, Shimei},
title = {Transcriptomic and Biochemical Analysis of the Antimicrobial Mechanism of Lipopeptide Iturin W against Staphylococcus aureus},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {18},
pages = {9949},
doi = {10.3390/ijms25189949}
}
EUVIMED